INTERESTED IN LEARNING MORE?

 At Orpheus Medica, we advance the therapeutic benefits of   cannabinoid-based medicines through our novel, proprietary, drug   development platform for the treatment of unmet medical needs. 

 INNOVATIVE PRODUCTS 
 SERVING THE GLOBAL PAIN 
 MANAGEMENT MARKET 
OUR PEOPLE
Our goal is to become a profitable and socially responsible company that develops treatments to improve the quality of life of patients with acute and/or chronic pain
Our scientific team, comprised of dedicated professionals, clinicians and biochemists, collectively has over 100+ years of research and pharmaceutical experience
Our vision is to develop targeted therapeutics that are poised to replace opioids for pain management in the pharmaceutical industry

info@orpheusmed.com
© Copyright 2019. All rights reserved.

INTERESTED IN LEARNING MORE?
GET IN TOUCH WITH US HERE
OUR PARTNERS
We are building on a strong and strategically positioned portfolio. Our diverse set of programs are focused on a broad portfolio of assets with targeted mechanism of action.
Unlocking the Next Generation Cannabinoid Medicines 

Cannabinoid (CBD) drug candidates are poised to rescue humanity from the opioid crisis. The challenge to make this happen is the design of consistent, highly effective, quality CBD-based drugs that satisfy unmet medical needs. Orpheus' scientific team meets this challenge with a robust and efficient systematic approach to drug development that meets pharmaceutical rigor and relies on screening a large number of CBD drug candidates to develop proven remedies associated with different diseases under investigation. 

WHO WE ARE
Orpheus Medica is a privately held Canadian biopharmaceutical company leading innovation in discovery, research and development of natural and novel cannabinoid therapeutic agents for musculoskeletal, joint, neuropathic pain and inflammatory diseases using a streamlined pharmaceutical development approach.
 Leveraging advanced computational biology and machine learning tools combined with state-of-the-art high-throughput drug-screening platform to create novel cannabinoid-based therapeutics for unmet medical needs 
OUR VISION
OUR ADVANTAGE
OUR GOAL
CONNECT WITH US
Follow Orpheus Medica on Facebook, LinkedIn and Twitter.
INTERESTED IN LEARNING MORE?

At Orpheus Medica, we advance the therapeutic benefits of cannabinoid-based medicines through our novel, proprietary, drug development platform for the treatment of unmet medical needs. 

INNOVATIVE PRODUCTS SERVING THE GLOBAL PAIN MANAGEMENT MARKET
OUR PARTNERS
We are building on a strong and strategically positioned portfolio. Our diverse set of programs are focused on a broad portfolio of assets with targeted mechanism of action.
Unlocking the Next Generation Cannabinoid Medicines
Cannabinoid (CBD) drug candidates are poised to rescue humanity from the opioid crisis. The challenge to make this happen is the design of consistent, highly effective, quality CBD-based drugs that satisfy unmet medical needs. Orpheus' scientific team meets this challenge with a robust and efficient systematic approach to drug development that meets pharmaceutical rigor and relies on screening a large number of CBD drug candidates to develop proven remedies associated with different diseases under investigation. 
OUR VISION
Our goal is to become a profitable and socially responsible company that develops treatments to improve the quality of life of patients with acute and/or chronic pain
Our scientific team, comprised of dedicated professionals, clinicians and biochemists, collectively has over 100+ years of research and pharmaceutical experience
Our vision is to develop targeted therapeutics that are poised to replace opioids for pain management in the pharmaceutical industry
WHO WE ARE
Orpheus Medica is a privately held Canadian biopharmaceutical company leading innovation in discovery, research and development of natural and novel cannabinoid therapeutic agents for musculoskeletal, joint, neuropathic pain and inflammatory diseases using a streamlined pharmaceutical development approach.
 Leveraging advanced computational biology and machine learning tools combined with state-of-the-art high-throughput drug-screening platform to create novel cannabinoid-based therapeutics for unmet medical needs 
OUR PEOPLE
OUR ADVANTAGE
OUR GOAL
CONNECT WITH US
Follow Orpheus Medica on Facebook, LinkedIn and Twitter.
INTERESTED IN LEARNING MORE?
GET IN TOUCH WITH US HERE

info@orpheusmed.com
© Copyright 2019. All rights reserved.